Versant Venture Capital VI, L.P.
LAVA Therapeutics N.V. · 10% Owner
Versant Venture Capital VI, L.P. is listed in public filings as 10 percent owner. This Versant Venture Capital VI, L.P. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include LAVA Therapeutics N.V. (LVTX), LENZ Therapeutics, Inc. (LENZ), and Monte Rosa Therapeutics, Inc. (GLUE). Investors use Versant Venture Capital VI, L.P.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.